ADC Therapeutics SA
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $81.4 | $70.8 | $69.6 | $209.9 | — |
| Operating income | -$121.5 | -$130.7 | -$166.0 | -$123.3 | — |
| Net income | -$142.6 | -$157.8 | -$240.1 | -$157.1 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$141.4 | -$124.7 | -$121.9 | -$139.0 | — |
Shares outstanding 127.2M · Free float 62.0%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.